Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

For Staff

Communications, branding and engagement

Find out about editing your website profile, get presentation templates,  and more. Here.

SOCIAL MEDIA

Join us on Facebook and Twitter.

intranet

Our new intranet has been launched. You can find relevant information on finance, HR, our working culture, buildings, communications, and latest news and updates.  You can also go here for room bookings, Health & Safety information, etc.

Latest news

Wrist pain

Speedy diagnosis and treatment are key for wrist injury patients

A new study supports the strategy of using early MRI scans to significantly improve care and experiences for patients with wrist injuries.

Karsten Carter receives treatment from Professor Simon Travis

NDORMS researchers deliver pioneering treatment for rare genetic condition

A team at NDORMS, University of Oxford has successfully administered a pioneering treatment to a patient with XIAP deficiency, a rare genetic disorder.

Gannets diving to catch crabs

TCRs drive CARs

Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer treatments. This study, published in Cell, demonstrates that engineering T-cells to express both a Chimeric Antigen Receptor (CAR) and a T-cell Receptor (TCR) can improve their ability to distinguish between cancerous and healthy tissues—addressing a major challenge in current immunotherapy.

Examining patient for skin cancer

Common virus may improve skin cancer treatment outcomes, study finds

A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.